Bayer AG (OTCMKTS:BAYRY) – Analysts at Jefferies Group reduced their FY2020 earnings estimates for shares of Bayer AG in a research note issued to investors on Tuesday. Jefferies Group analyst J. Holford now forecasts that the company will post earnings per share of $2.47 for the year, down from their previous estimate of $2.74. Jefferies Group also issued estimates for Bayer AG’s FY2021 earnings at $2.66 EPS.

TRADEMARK VIOLATION WARNING: “Bayer AG to Post FY2020 Earnings of $2.47 Per Share, Jefferies Group Forecasts (BAYRY)” was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this article on another site, it was copied illegally and republished in violation of U.S. & international copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/11/15/bayer-ag-to-post-fy2020-earnings-of-2-47-per-share-jefferies-group-forecasts-bayry.html.

BAYRY has been the subject of a number of other reports. BNP Paribas upgraded shares of Bayer AG from a “neutral” rating to an “outperform” rating in a research note on Monday, September 25th. Zacks Investment Research raised shares of Bayer AG from a “hold” rating to a “buy” rating and set a $148.00 price target for the company in a research report on Tuesday, September 19th. Finally, ValuEngine lowered shares of Bayer AG from a “buy” rating to a “hold” rating in a research report on Friday, September 22nd. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Bayer AG has an average rating of “Buy” and a consensus target price of $148.00.

Bayer AG (BAYRY) traded down $0.04 during mid-day trading on Wednesday, reaching $31.97. 202,872 shares of the company were exchanged, compared to its average volume of 522,707. The firm has a market cap of $105,121.89, a PE ratio of 15.79, a PEG ratio of 2.37 and a beta of 1.13. The company has a quick ratio of 1.29, a current ratio of 1.74 and a debt-to-equity ratio of 0.40. Bayer AG has a one year low of $22.88 and a one year high of $35.41.

Bayer AG Company Profile

Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology.

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.